Published in Saudi J Gastroenterol on September 25, 2014
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis | NCT02335580
Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology (2003) 3.19
De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol (2013) 2.22
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology (2012) 1.65
Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology (1995) 1.56
Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol (2014) 1.07
Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol (1992) 1.02
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol (2013) 0.96
Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses (2011) 0.94
Anticoagulation for portal vein thrombosis in cirrhosis. Am J Med (2010) 0.87
Doppler ultrasound of hepatic blood flow for noninvasive evaluation of liver fibrosis compared with liver biopsy and transient elastography. Dig Dis Sci (2012) 0.85
Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol (2014) 0.84
The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med (2004) 2.46
Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int (2013) 2.22
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol (2010) 2.11
MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun (2010) 1.80
Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol (2010) 1.79
Prevalence of covert duplicate publications in Budd-Chiari syndrome articles in China: a systematic analysis. Am J Med (2013) 1.63
The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol (2006) 1.57
MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol (2005) 1.53
Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol (2013) 1.49
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. Am J Respir Cell Mol Biol (2007) 1.41
Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology (2013) 1.39
Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt. Hepatology (2010) 1.39
Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology (2014) 1.27
Limb sparing surgery for bone tumours of the shoulder girdle: the oncological and functional results. Int Orthop (2009) 1.25
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology (2012) 1.12
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol (2012) 1.12
Closing the yield gap could reduce projected greenhouse gas emissions: a case study of maize production in China. Glob Chang Biol (2013) 1.09
Air pollution particles diminish bacterial clearance in the primed lungs of mice. Toxicol Appl Pharmacol (2007) 1.08
Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol (2013) 1.07
MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells. J Cell Sci (2013) 1.06
MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett (2013) 1.05
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol (2011) 1.00
Scavenger receptors and β-glucan receptors participate in the recognition of yeasts by murine macrophages. Inflamm Res (2011) 0.94
Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses (2011) 0.94
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) (2016) 0.90
A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract. Int J Med Sci (2013) 0.90
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost (2015) 0.90
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.90
Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review. Asia Pac J Clin Oncol (2013) 0.89
Custom prosthetic reconstruction for proximal tibial osteosarcoma with proximal tibiofibular joint involved. Surg Oncol (2007) 0.89
Stage of portal vein thrombosis. J Hepatol (2010) 0.88
Degree of portal vein thrombosis. Hepatology (2010) 0.87
Anticoagulation for portal vein thrombosis in cirrhosis. Am J Med (2010) 0.87
Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies. Hepatol Res (2014) 0.87
Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol (2014) 0.86
[Blood lead level of children in the urban areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 0.85
Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res (2012) 0.84
R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction. Mol Pharm (2010) 0.83
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res (2013) 0.83
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc Intervent Radiol (2014) 0.82
Function of miRNA in controlling drug resistance of human cancers. Curr Drug Targets (2013) 0.82
Particle-epithelial interaction: effect of priming and bystander neutrophils on interleukin-8 release. Am J Respir Cell Mol Biol (2003) 0.82
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit (2012) 0.81
Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering. Injury (2013) 0.81
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol (2014) 0.81
The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology (2010) 0.81
Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway. Tumour Biol (2014) 0.80
Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One (2013) 0.80
Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol (2016) 0.79
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma. Hepatology (2012) 0.79
Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis. Curr Stem Cell Res Ther (2015) 0.79
l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol (2013) 0.79
Hepatocellular carcinoma. Lancet (2012) 0.78
Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge. Carbohydr Polym (2012) 0.78
Effects of dietary live yeast Hanseniaspora opuntiae C21 on the immune and disease resistance against Vibrio splendidus infection in juvenile sea cucumber Apostichopus japonicus. Fish Shellfish Immunol (2012) 0.77
Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures. Medicine (Baltimore) (2015) 0.77
Degree of portal vein thrombosis might be associated with recanalization during anticoagulation. Clin Gastroenterol Hepatol (2012) 0.77
Stem cell associated genes working with one miRNA cluster have different clinic pathologic values in gastric cancer. Pathol Oncol Res (2011) 0.77
Diagnostic accuracy of data on aspartate aminotransferase to platelets index might be false in the paper by Tafarel et al. Eur J Gastroenterol Hepatol (2015) 0.77
MiRNAs in human cancers: the diagnostic and therapeutic implications. Curr Pharm Des (2014) 0.77
A large portal vein: a rare finding of recent portal vein thrombosis. Case Rep Gastroenterol (2011) 0.77
Directions of odds ratios might be inappropriate in the paper by Tafarel et al. Eur J Gastroenterol Hepatol (2015) 0.77
Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis. Gene (2012) 0.77
Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. J Biol Chem (2012) 0.77
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open (2013) 0.76
Prevalence of hepatocellular carcinoma in Chinese Budd-Chiari syndrome patients: an extended systematic review using Chinese-language databases. Eur J Gastroenterol Hepatol (2013) 0.75
Portal vein thrombosis significantly improves the survival of cirrhotic patients awaiting liver transplantation: should we accept the statistical results? Eur J Intern Med (2015) 0.75
Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat? Radiology (2013) 0.75
Coagulopathy of chronic liver disease. N Engl J Med (2011) 0.75
Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension? Liver Int (2012) 0.75
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis. Gut (2011) 0.75
Universal insurance coverage and health care inequity. Ann Intern Med (2009) 0.75
Anticoagulation and variceal bleeding in non-cirrhotic patients with portal vein thrombosis. Intern Emerg Med (2010) 0.75
A confusing relationship between Child-Turcotte-Pugh class A and compensated cirrhosis. Am J Gastroenterol (2010) 0.75
4-Bromo-1-[2,6-dichloro-4-(trifluoro-meth-yl)phen-yl]-5-(4-methoxy-benzyl-ideneamino)-1H-pyrazole-3-carbonitrile. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Sm(3+)-doped Ba3Bi(PO4)3 orange reddish emitting phosphor. Spectrochim Acta A Mol Biomol Spectrosc (2013) 0.75
Disseminated plasmacytomas in multiple myeloma: atypical presentations on multimodality images, emphasized on PET/CT. Ann Hematol (2013) 0.75
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turk J Gastroenterol (2016) 0.75
A histological evaluation on osteogenesis and resorption of methotrexate-loaded calcium phosphate cement in vivo. Biomed Mater (2010) 0.75
Albumin-bilirubin, Child-Pugh, and model for end-stage liver disease scores for the assessment of prognosis in cirrhotic patients. Turk J Gastroenterol (2017) 0.75
UV-excited red-emitting phosphor Eu3+-activated Ca9Y(PO4)7. Spectrochim Acta A Mol Biomol Spectrosc (2011) 0.75
[Nutritional characteristics of Caragana jubata shrub and distribution patterns of soil nutrients in Luya Mountain]. Ying Yong Sheng Tai Xue Bao (2006) 0.75
Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs. Thromb Haemost (2015) 0.75
[Effects of applying L-methionine, L-phenylalanine and L-tryptophan on Zea mays growth and its nutrient uptake]. Ying Yong Sheng Tai Xue Bao (2005) 0.75
Education and Imaging. Hepatobiliary and pancreatic: inferior mesenteric vein-left gonadal vein shunt aggravating hepatic encephalopathy. J Gastroenterol Hepatol (2012) 0.75
Structure, luminescence properties and energy transfer of Tb(3+)-Eu(3+) codoped LiBaB9O15 phosphors. Dalton Trans (2015) 0.75
[Growth inhibition and apoptosis-inducing effects of phytic acid in human gastric carcinoma cells]. Wei Sheng Yan Jiu (2010) 0.75
Hydrothermal Synthesis and Luminescent Properties of Eu3+ Doped Sr3Al2O6 Phosphor for White LED. J Nanosci Nanotechnol (2016) 0.75
[Blocking effect of phytic acid on cell proliferation in human gastric carcinoma]. Wei Sheng Yan Jiu (2008) 0.75
[Effects of irradiance on boron requirement of phaseolus aureus cutting for its adventitious root development]. Ying Yong Sheng Tai Xue Bao (2006) 0.75
Do not let precision medicine be kidnapped. Front Med (2015) 0.75
Large paraesophageal varices causing recurrent hepatic encephalopathy. Am J Med Sci (2014) 0.75
Skeletal lesions in primary hyperparathyroidism. Am J Med Sci (2015) 0.75
[Effect of straw return to field and fertilization in autumn on dryland corn growth and on water and fertilizer efficiency]. Ying Yong Sheng Tai Xue Bao (2004) 0.75
Synthesis and Luminescent Properties of Eu2+ Doped Sr5SiO4Cl6 Phosphor by Sol-Gel Method. J Nanosci Nanotechnol (2016) 0.75
Complete remission of hepatocellular carcinoma after transarterial Chemoembolization combined with brivanib. J Cancer Res Ther (2015) 0.75